Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK…
Biotechnology
US, Berkeley Heights [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Cyclacel Pharmaceuticals, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDCyclacel Pharmaceuticals, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Cyclacel Pharmaceuticals, Inc..
If you want to see a demo, head over to the financial segments of AAPL